SCHEMBL30102602

SCHEMBL30102602

N#Cc1ccccc1-c1cnccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.43
ADRA1B P35368 2/20 0.43
ALDH1A1 P00352 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA5 P31644 1/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ADRA1D P25100 1/20 0.43
HTT P42858 1/20 0.42
ALOX5AP P20292 3/20 0.42
FEN1 P39748 3/20 0.42
METAP2 P50579 1/20 0.41
ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10427641 1.00 ADRA1A (0.43) ADRA1AADRA1BALDH1A1GABRG2GABRB3
SCHEMBL29669833 1.00 ADRA1A (0.43) ADRA1AADRA1BALDH1A1GABRG2GABRB3
SCHEMBL30719203 0.83 HTT (0.41) ALDH1A1GABRG2GABRB3GABRA3GABRA5
SCHEMBL5337044 0.82 ADRA1A (0.43) ADRA1AADRA1BALDH1A1MEN1KMT2A
SCHEMBL31070227 0.79 GRIA1 (0.51) ALDH1A1GABRG2GABRB3GABRA3GABRA5
SCHEMBL30102603 0.79 GRIA1 (0.51) ALDH1A1GABRG2GABRB3GABRA3GABRA5
SCHEMBL973015 0.79 GRIA1 (0.51) ALDH1A1GABRG2GABRB3GABRA3GABRA5
SCHEMBL12853973 0.78 ALOX5AP (0.50) ADRA1AADRA1BALDH1A1MEN1CYP1A2
SCHEMBL12853984 0.78 ALOX5AP (0.50) ADRA1AADRA1BALDH1A1MEN1CYP1A2
SCHEMBL28622199 0.78 GRM5 (0.41) ALDH1A1CYP1A2HPGDMETAP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117597345-A Heterocyclic derivatives as CaMKK2 inhibitors 百时美施贵宝公司 2024-02-23 CN disclosed
CN-117500503-A Combination therapy comprising an A2A/A2B inhibitor, a PD-1/PD-L1 inhibitor and an anti-CD 73 antibody 因赛特公司 2024-02-02 CN disclosed
CN-117304191-A Fused pyrazine derivatives as A2A/A2B inhibitors 因赛特公司 2023-12-29 CN disclosed
CN-115551595-A Combination therapy of a CD73 inhibitor and an A2A/A2B adenosine receptor inhibitor 因赛特公司 2022-12-30 CN disclosed